Joel Isaacson & Co. LLC Has $1.41 Million Holdings in Colgate-Palmolive Company $CL

Joel Isaacson & Co. LLC grew its position in Colgate-Palmolive Company (NYSE:CL) by 70.4% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 17,792 shares of the company’s stock after purchasing an additional 7,353 shares during the quarter. Joel Isaacson & Co. LLC’s holdings in Colgate-Palmolive were worth $1,406,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. ProShare Advisors LLC raised its position in shares of Colgate-Palmolive by 11.0% in the 3rd quarter. ProShare Advisors LLC now owns 2,047,542 shares of the company’s stock valued at $163,681,000 after buying an additional 202,379 shares in the last quarter. Providence Capital Advisors LLC acquired a new position in shares of Colgate-Palmolive in the 3rd quarter valued at approximately $5,373,000. Asset Management One Co. Ltd. raised its position in shares of Colgate-Palmolive by 3.9% in the 3rd quarter. Asset Management One Co. Ltd. now owns 422,292 shares of the company’s stock valued at $33,758,000 after buying an additional 16,017 shares in the last quarter. Citigroup Inc. raised its position in shares of Colgate-Palmolive by 43.7% in the 3rd quarter. Citigroup Inc. now owns 1,346,590 shares of the company’s stock valued at $107,646,000 after buying an additional 409,710 shares in the last quarter. Finally, TD Waterhouse Canada Inc. raised its position in shares of Colgate-Palmolive by 248.5% in the 3rd quarter. TD Waterhouse Canada Inc. now owns 87,410 shares of the company’s stock valued at $6,909,000 after buying an additional 62,327 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the stock. The Goldman Sachs Group restated a “buy” rating and issued a $100.00 target price on shares of Colgate-Palmolive in a research report on Friday, February 20th. JPMorgan Chase & Co. dropped their target price on shares of Colgate-Palmolive from $97.00 to $95.00 and set an “overweight” rating for the company in a research report on Friday, April 17th. TD Cowen reaffirmed a “hold” rating and set a $85.00 price target on shares of Colgate-Palmolive in a report on Tuesday, March 31st. Citigroup lifted their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a report on Monday, February 2nd. Finally, UBS Group decreased their price target on shares of Colgate-Palmolive from $100.00 to $98.00 and set a “buy” rating on the stock in a report on Tuesday, April 7th. Twelve research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average target price of $95.56.

Insider Activity

In other news, CFO Stanley J. Sutula III sold 97,843 shares of the business’s stock in a transaction that occurred on Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total value of $9,223,659.61. Following the transaction, the chief financial officer owned 55,310 shares in the company, valued at approximately $5,214,073.70. The trade was a 63.89% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Sally Massey sold 15,851 shares of the business’s stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the completion of the transaction, the insider owned 13,751 shares in the company, valued at $1,306,757.53. This trade represents a 53.55% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 184,683 shares of company stock worth $17,486,693 over the last quarter. Company insiders own 0.43% of the company’s stock.

Colgate-Palmolive Trading Down 1.4%

CL opened at $84.50 on Thursday. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $99.33. The company has a debt-to-equity ratio of 18.82, a current ratio of 0.83 and a quick ratio of 0.54. The firm has a market capitalization of $67.80 billion, a price-to-earnings ratio of 32.25, a PEG ratio of 4.31 and a beta of 0.34. The company’s 50 day moving average price is $88.12 and its two-hundred day moving average price is $84.05.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. The firm had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.91 EPS. As a group, research analysts predict that Colgate-Palmolive Company will post 3.85 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Monday, April 20th will be given a $0.53 dividend. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date is Monday, April 20th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.5%. Colgate-Palmolive’s dividend payout ratio is presently 80.92%.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.